Custom‑Made Drug from The Hague Sent to Seven Indian Children

A pharmaceutical compound uniquely formulated in The Hague has been sent to India for a group of seven children who need the medication. The drug, tailored to address a rare medical condition, was manufactured by a Dutch facility with expertise in custom therapies.
The Indian recipients are expected to receive the treatment under a coordinated medical program, though details of the condition have not been disclosed publicly. Health officials in India have confirmed the arrival of the medication and are preparing for its administration.
The collaboration highlights cross‑border cooperation in delivering advanced treatments to patients with limited options, and underscores the role of specialized manufacturing hubs in addressing rare disease needs worldwide.